TNON Stock Analysis: Buy, Sell, or Hold?
TNON - Tenon Medical, Inc. Common Stock
$0.28
-0.01 (-4.89%)
▼
5d:
-45.7%
30d:
-55.87%
90d:
-61.15%
HOLD
MODERATE Confidence
Analysis Updated: Jul 6, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When TNON Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called TNON this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TNON shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: TNON shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: TNON is currently trading at $0.28, which is considered oversold relative to its 30-day fair value range of $0.41 to $0.67.
Technical Outlook: Technically, TNON is in a downtrend. The price is currently testing key support at $0.58. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: TNON has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.62 (+844.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TNON is in a downtrend. The price is currently testing key support at $0.58. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: TNON has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.62 (+844.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.41 -
$0.67
Company Quality Score
51/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BEARISH: Downward momentum (-4.9%)
- BULLISH: Trading 844.2% below Wall St target ($2.62)
- CAUTION: 5-day price weakness (-45.7%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.41 -
$0.67
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.58
Resistance Level
$0.72
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.46
Wall Street Target
$2.63
(+844.2%)
Revenue Growth (YoY)
89.9%
Profit Margin
-270.1%
Share & Embed Analysis
Last updated: July 06, 2026 6:12 PM ET
Data refreshes hourly during market hours. Next update: 7:12 PM
Data refreshes hourly during market hours. Next update: 7:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNON showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$75 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 65 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 62 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 65 BUY |
